Tandem Diabetes Care (NSDQ:TNDM) has registered for a $40 million offering of its common stock, according to an SEC filing posted today.
Shareholders for the San Deigo, Calif.-based company approved a proposal last year to effect a 1-for-10 reverse stock split that they believed would help make Tandem’s stock more attractive to institutional investors.
Get the full story at our sister site, Drug Delivery Business News.
The post Tandem Diabetes registers $40m offering appeared first on MassDevice.